Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
Elon Musk’s Boring Company Raises $3 Billion at $23 Billion Valuation 
Nvidia-Groq AI Chip Deal Faces U.S. Antitrust Probe 
Enflame Shares Surge 200% in Shanghai AI Chip Debut 
UK Economy Grows 0.4% in July, Beating Forecasts 
Boeing, SPEEA Reach Tentative Four-Year Labor Deal 
UK Food Inflation Forecast to Hit 6.4% by Mid-2027 
Nvidia Plans 2GW Australia AI Data Center Expansion by 2027 
Judge Rejects Minnesota Bid to Force ICE Agent Extradition 
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
US Judge Dismisses Gautam Adani Criminal Charges 
Google Revamps EU Search Results to Meet DMA Rules 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
Gold Prices Steady as Hot PPI Boosts Fed Rate Hike Bets 
Japanese Yen Nears Seven-Month High as Oil Approaches $100 
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak 
29 US states are suing Meta. What might it mean for the rest of the world? 
Add as a preferred source on Google
Johnson & Johnson (J&J) has sued drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs, and at least $25 million in damages from each defendant.
Patients complaining about receiving the wrong pills in their prescription bottles led J&J to discover widespread counterfeiting, as did the voluntary return of hundreds of bottles of counterfeit pharmaceuticals from one of the defendants, distributor ProPharma Distribution LLC.
Following Gilead Sciences Inc.'s lawsuit in January, the firm said it became aware of the sale of counterfeit versions of its HIV medications. Symtuza, a multi-drug combination treatment, as well as Prezcobix, Prezista, and Edurant, are among the medications at issue.
J&J claims that counterfeit bottles occasionally included a different HIV medicine than what was advertised on the label and that one counterfeit bottle contained the strong antipsychotic Seroquel.
The defendants include ProPharma, Safe Chain Solutions LLC, and Scripts Wholesale Inc, as well as drugstore operator I Care Pharmacy 14 and the business' individual proprietors.
According to the lawsuit, I Care Pharmacy had a physical location in New York City that was closed down immediately after a fraudulent transaction was found.
J&J believes the pharmacy is linked to a criminal counterfeiting network that is still operational in New York City, dispensing hazardous counterfeit HIV medication.
